Browsing: Alzheimers

Company targets confirmatory trials of immunomodulator shown to slow cognitive decline when used as a control arm. Longevity biotech Advantage…

Credit: Lars Neumann/Getty Images Researchers at the University of Southern California (USC) have developed a noninvasive method to measure the…

Looking ahead, Piller remains cautiously optimistic. Despite the setbacks and missteps, he sees a field ready for change, driven by…

Hormone levels change a lot after menopause. Most notably, estrogen levels fall sharply and remain at a low baseline level.…

By far, the most interesting (and terrifying) element of this case study is that no known gene mutations were identified…

Alzheimer’s disease has proved to be a tricky target, and researchers and drug developers have been pursuing effective treatments for…

Alzheimer’s disease (AD) is the most common form of dementia affecting approximately 55 million people worldwide. In a new study…

More than 1000 NHS patients across the UK will be offered a new blood test to detect Alzheimer’s disease in…

There are over 7 million Americans currently living with Alzheimer’s disease, and women account for a staggering two-thirds of that…

Lecanemab (Leqembi), the first drug to show an ability to slow cognitive decline in Alzheimer’s disease, will be available for…